Sebetralstat for On-demand Treatment of Hereditary Angioedema Attacks: US Subgroup Analysis from the Double-blind, Placebo-controlled Phase 3 KONFIDENT Trial

 

YOU ARE NOW LEAVING KALVISTA.COM

You are now being directed to another KalVista website that contains information about specific treatment(s)

PROCEED TO SITE >>> Cancel